Answer
Women of childbearing potential should use effective contraception throughout treatment with tofacitinib citrate and for at least 4 weeks after the last dose.
Sources for this answer
- XELJANZ 5mg film-coated tabletsPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 33Document updated
Sources checked